BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Leukocyte
,
Neocentromeres
,
Cisplatin
,
rs4950928
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VEGFR2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Omental adipose tissue
Pericardium
Lung
Thyroid gland
Kidney cortex
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive I…
VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransducti…
Coordinated Activation of VEGF/VEGFR-2 and PPARĪ“ Pathways by a Multi-Component Chinese Medicine DHI …
Targeting the VEGFR2 signaling pathway for angiogenesis and fibrosis regulation in neovascular age-r…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
A Study of Anti-VEGFR2 AK109 in Subjects With Advanced Solid Tumors
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced Sarcoma
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients Wit…
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients Wit…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ